These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21790289)

  • 41. Scleroderma gene expression and pathway signatures.
    Sargent JL; Milano A; Connolly MK; Whitfield ML
    Curr Rheumatol Rep; 2008 Jul; 10(3):205-11. PubMed ID: 18638428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis.
    Leask A
    Pharmacol Res; 2011 Jun; 63(6):502-3. PubMed ID: 21315153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
    Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated Fibronectin Levels in Profibrotic CD14
    Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
    Front Immunol; 2021; 12():642891. PubMed ID: 34504485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of alterations in X-linked IRAK1gene and miR-146a on susceptibility and clinical manifestations in patients with systemic sclerosis.
    Vreca M; Andjelkovic M; Tosic N; Zekovic A; Damjanov N; Pavlovic S; Spasovski V
    Immunol Lett; 2018 Dec; 204():1-8. PubMed ID: 30308218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.
    Tan FK; Zhou X; Mayes MD; Gourh P; Guo X; Marcum C; Jin L; Arnett FC
    Rheumatology (Oxford); 2006 Jun; 45(6):694-702. PubMed ID: 16418202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
    Asano Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
    MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
    J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.
    Tanaka S; Suto A; Ikeda K; Sanayama Y; Nakagomi D; Iwamoto T; Suzuki K; Kambe N; Matsue H; Matsumura R; Kashiwakuma D; Iwamoto I; Nakajima H
    Rheumatology (Oxford); 2013 Nov; 52(11):1963-72. PubMed ID: 23893664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Takehara K
    Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of TLR7, TLR9, JAK2, and STAT3 genes in peripheral blood mononuclear cells from patients with systemic sclerosis.
    Vreća M; Zeković A; Damjanov N; Andjelković M; Ugrin M; Pavlović S; Spasovski V
    J Appl Genet; 2018 Feb; 59(1):59-66. PubMed ID: 29147913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosis.
    Wipff J; Avouac J; Le Charpentier M; Varret M; Houtteman A; Ruiz B; Vacher-Lavenu MC; Kahan A; Boileau C; Allanore Y
    Rheumatology (Oxford); 2010 Apr; 49(4):657-61. PubMed ID: 20081226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated expression of cav-1 in a subset of SSc fibroblasts contributes to constitutive Alk1/Smad1 activation.
    Haines P; Hant FN; Lafyatis R; Trojanowska M; Bujor AM
    J Cell Mol Med; 2012 Sep; 16(9):2238-46. PubMed ID: 22277251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.
    Avouac J; Cagnard N; Distler JH; Schoindre Y; Ruiz B; Couraud PO; Uzan G; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2011 Nov; 63(11):3552-62. PubMed ID: 21769840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
    Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
    Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
    Man XY; Finnson KW; Baron M; Philip A
    Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients.
    Zhou B; Zuo XX; Li YS; Gao SM; Dai XD; Zhu HL; Luo H
    Sci Rep; 2017 Feb; 7():42899. PubMed ID: 28211533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis.
    Favoino E; Favia IE; Vettori S; Vicenti C; Prete M; Valentini G; Perosa F
    Clin Exp Immunol; 2015 Jul; 181(1):100-9. PubMed ID: 25847615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.